1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
|
ID DI500001 STANDARD; PRT; 111 AA.
XX
AC DI500001;
XX
DT 21-FEB-2008
XX
DE KR 1020047013665-A/4: INTERNALIZING ANTI-CD-74 ANTIBODIES AND
DE METHODS OF USE.
XX
KW KR 1020047013665-A/4.
XX
OS Mus musculus (house mouse)
OC Mus musculus
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
OC Sciurognathi; Muroidea; Muridae; Murinae; Mus; Mus.
XX
RN []
RP [-]
RA Hansen,H., Leung,S., Qu,Z. and Goldenberg,D.M.;
RT "INTERNALIZING ANTI-CD-74 ANTIBODIES AND METHODS OF USE";
RL Patent: KR 1020047013665-A/4 01-SEP-2004.
XX
FH Key Location/Qualifiers
FT source 1..111
XX
SQ SEQUENCE 111 AA; 749F21BE CRC32;
DVVMTQTPLS LPVSLGDQAS ISCRSSQSLV HRNGNTYLHW YLQKPGQSPK LLIYTVSNRF 60
SGVPDRFSGS GSGTDFTLKI SRVEAEDLGL YFCSQSSHVP PTFGAGTKLE I 111
//
ID DI500002 STANDARD; PRT; 27 AA.
XX
AC DI500002;
XX
DT 30-APR-2009
XX
DE KR 1020047013597-A/36: Conjugates of Therapeutic or Cytotoxic
DE Agents and Biologically Active Peptides.
XX
KW KR 1020047013597-A/36.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Fuselier,J.A. and Coy,D.H.;
RT "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT Active Peptides";
RL Patent: KR 1020047013597-A/36 31-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..27
XX
SQ SEQUENCE 27 AA; 78E70892 CRC32;
GSSSSSSSSS SSSSSSSXYS CFWKTCT 27
//
ID DI500003 standard; PRT; 7 AA.
XX
AC DI500003;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/161: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/161.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/161 20-AUG-2004.
XX
FH Key Location/Qualifiers
FH Key Location/Qualifiers
FT source 1..7
FT /db_xref="taxon:32630"
FT /organism="synthetic construct"
XX
SQ Sequence 7 AA;
GSSNRAT 7
//
ID DI500004 STANDARD; PRT; 141 AA.
XX
AC DI500004;
XX
DT 21-FEB-2008
XX
DE KR 1020047013224-A/144: METHOD FOR THE RECOMBINATION OF GENETIC
DE ELEMENTS.
XX
KW KR 1020047013224-A/144.
XX
OS Klebsiella pneumoniae
OC Klebsiella pneumoniae
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC Enterobacteriaceae; Klebsiella.
XX
RN []
RP [-]
RA Milano,J. and Tang,X.;
RT "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL Patent: KR 1020047013224-A/144 25-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..141
XX
SQ SEQUENCE 141 AA; B10429EF CRC32;
MSEKTMRVQD YPLATRCPEH ILTPTGKPLT DITLEKVLSG EVGPQDVRIS RQTLEYQAQI 60
AEQMQRHAVA RNFRRAAELI AIPDERILAI YNALRPFRSS QAELLAIADE LEHTWHATVN 120
AAFVRESAEV YQQRHKLRKG S 141
//
ID DI500005 STANDARD; PRT; 31 AA.
XX
AC DI500005;
XX
DT 21-FEB-2008
XX
DE KR 1020047012920-A/1: METHOD FOR ADMINISTERING GLP-1 MOLECULES.
XX
KW KR 1020047012920-A/1.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Khan,M.A., Jones,B.E. and Mcgill,J.M.;
RT "METHOD FOR ADMINISTERING GLP-1 MOLECULES";
RL Patent: KR 1020047012920-A/1 19-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..31
XX
SQ SEQUENCE 31 AA; 91FF0930 CRC32;
HAEGTFTSDV SSYLEGQAAK EFIAWLVKGR X 31
//
ID DI500006 STANDARD; PRT; 17 AA.
XX
AC DI500006;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/181: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/181.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/181 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..17
XX
SQ SEQUENCE 17 AA; 2DE10526 CRC32;
AINATGYRTY YADSVKG 17
//
ID DI500007 STANDARD; PRT; 22 AA.
XX
AC DI500007;
XX
DT 30-APR-2009
XX
DE KR 1020047013597-A/31: Conjugates of Therapeutic or Cytotoxic
DE Agents and Biologically Active Peptides.
XX
KW KR 1020047013597-A/31.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Fuselier,J.A. and Coy,D.H.;
RT "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT Active Peptides";
RL Patent: KR 1020047013597-A/31 31-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..22
XX
SQ SEQUENCE 22 AA; 509706F3 CRC32;
GSSSSSSSSS SSXYSCFWKT CT 22
//
ID DI500008 STANDARD; PRT; 3 AA.
XX
AC DI500008;
XX
DT 30-APR-2009
XX
DE KR 1020047013597-A/12: Conjugates of Therapeutic or Cytotoxic
DE Agents and Biologically Active Peptides.
XX
KW KR 1020047013597-A/12.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Fuselier,J.A. and Coy,D.H.;
RT "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT Active Peptides";
RL Patent: KR 1020047013597-A/12 31-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..3
XX
SQ SEQUENCE 3 AA; 1E900F8 CRC32;
KYS 3
//
ID DI500009 STANDARD; PRT; 17 AA.
XX
AC DI500009;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/379: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/379.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/379 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..17
XX
SQ SEQUENCE 17 AA; 2E5C0539 CRC32;
GKGNTHKPYG YVRYFDV 17
//
ID DI500010 STANDARD; PRT; 8 AA.
XX
AC DI500010;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/107: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/107.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/107 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..8
XX
SQ SEQUENCE 8 AA; BAF0297 CRC32;
QQTYNYPP 8
//
ID DI500011 STANDARD; PRT; 716 AA.
XX
AC DI500011;
XX
DT 21-FEB-2008
XX
DE KR 1020047013224-A/14: METHOD FOR THE RECOMBINATION OF GENETIC
DE ELEMENTS.
XX
KW KR 1020047013224-A/14.
XX
OS unidentified
OC unidentified
OC unclassified sequences.
XX
RN []
RP [-]
RA Milano,J. and Tang,X.;
RT "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL Patent: KR 1020047013224-A/14 25-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..716
XX
SQ SEQUENCE 716 AA; 96B3D52B CRC32;
MAPSLDSISH SFANGVASAK QAVNGASTNL AVAGSHLPTT QVTQVDIVEK MLAAPTDSTL 60
ELDGYSLNLG DVVSAARKGR PVRVKDSDEI RSKIDKSVEF LRSQLSMSVY GVTTGFGGSA 120
DTRTEDAISL QKALLEHQLC GVLPSSFDSF RLGRGLENSL PLEVVRGAMT IRVNSLTRGH 180
SAVRLVVLEA LTNFLNHGIT PIVPLRGTIS ASGDLSPLSY IAAAISGHPD SKVHVVHEGK 240
EKILYAREAM ALFNLEPVVL GPKEGLGLVN GTAVSASMAT LALHDAHMLS LLSQSLTAMT 300
VEAMVGHAGS FHPFLHDVTR PHPTQIEVAG NIRKLLEGSR FAVHHEEEVK VKDDEGILRQ 360
DRYPLRTSPQ WLGPLVSDLI HAHAVLTIEA GQSTTDNPLI DVENKTSHRG GNFQAAAVAN 420
TMEKTRLGLA QIGKLNFTQL TEMLNAGMNR GLPSCLAAED PSLSYHCKGL DIAAAAYTSE 480
LGHLANPVTT HVQPAEMANQ AVNSLALISA RRTTESNDVL SLLLATHLYC VLQAIDLRAT 540
EFEFKKQFGP AIVSLIDQHF GSAMTGSNLR DELVEKVNKT LAKRLEQTNS YDLVPRWHDA 600
FSFAAGTVVE VLSSTSLSLA AVNAWKVAAA ESAISLTRQV RETFWSAAST SSPALSYLSP 660
RTQILYAFVR EELGVKARRG DVFLGKQEVT IGSNVSKIYE AIKSGRINNV LLKMLA 716
//
ID DI500012 STANDARD; PRT; 8 AA.
XX
AC DI500012;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/105: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/105.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/105 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..8
XX
SQ SEQUENCE 8 AA; B87028D CRC32;
QQTYDYPP 8
//
ID DI500013 STANDARD; PRT; 111 AA.
XX
AC DI500013;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/229: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/229.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/229 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..111
XX
SQ SEQUENCE 111 AA; 72F521FD CRC32;
DIVLTQPPSV SGAPGQRVTI SCSGSSSNIG SNYVSWYQQL PGTAPKLLIY DNNQRPSGVP 60
DRFSGSKSGT SASLAITGLQ SEDEADYYCQ SXDXXXXXXV FGGGTKLTVL G 111
//
ID DI500014 STANDARD; PRT; 141 AA.
XX
AC DI500014;
XX
DT 21-FEB-2008
XX
DE KR 1020047013224-A/90: METHOD FOR THE RECOMBINATION OF GENETIC
DE ELEMENTS.
XX
KW KR 1020047013224-A/90.
XX
OS Klebsiella pneumoniae
OC Klebsiella pneumoniae
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC Enterobacteriaceae; Klebsiella.
XX
RN []
RP [-]
RA Milano,J. and Tang,X.;
RT "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL Patent: KR 1020047013224-A/90 25-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..141
XX
SQ SEQUENCE 141 AA; B10429EF CRC32;
MSEKTMRVQD YPLATRCPEH ILTPTGKPLT DITLEKVLSG EVGPQDVRIS RQTLEYQAQI 60
AEQMQRHAVA RNFRRAAELI AIPDERILAI YNALRPFRSS QAELLAIADE LEHTWHATVN 120
AAFVRESAEV YQQRHKLRKG S 141
//
ID DI500015 STANDARD; PRT; 644 AA.
XX
AC DI500015;
XX
DT 21-FEB-2008
XX
DE KR 1020047015479-A/4: GENES ENCODING ACETOLACTATE SYNTHASE.
XX
KW KR 1020047015479-A/4.
XX
OS unidentified
OC unidentified
OC unclassified sequences.
XX
RN []
RP [-]
RA Kaku,K., Shimizu,T., Kawai,K., Nagayama,K., Fukuda,A. and Tanaka,Y.;
RT "GENES ENCODING ACETOLACTATE SYNTHASE";
RL Patent: KR 1020047015479-A/4 30-SEP-2004.
XX
FH Key Location/Qualifiers
FT source 1..644
XX
SQ SEQUENCE 644 AA; 973ABF27 CRC32;
MATTAAAAAA ALSAAATAKT GRKNHQRHHV LPARGRVGAA AVRCSAVSPV TPPSPAPPAT 60
PLRPWGPAEP RKGADILVEA LERCGVSDVF AYPGGASMEI HQALTRSPVI TNHLFRHEQG 120
EAFAASGYAR ASGRVGVCVA TSGPGATNLV SALADALLDS VPMVAITGQV HRRMIGTDAF 180
QETPIVEVTR SITKHNYLVL DVEDIPRVIQ EAFFLASSGR PGPVLVDIPK DIQQQMAVPV 240
WDTSMNLPGY IARLPKPPAT ELLEQVLRLV GESRRPILYV GGGCSASGDE LRWFVELTGI 300
PVTTTLMGLG NFPSDDPLSL RMLGMHGTVY ANYAVDKADL LLAFGVRFDD RVTGKIEAFA 360
SRAKIVHIDI DPAEIGKNKQ PHVSICADVK LALQGLNALL QQSTTKTSSD FSAWHNELDQ 420
QKREFPLGYK TFGEEIPPQY AIQVLDELTK GEAIIATGVG QHQMWAAQYY TYKRPRQWLS 480
SAGLGAMGFG LPAAAGASVA NPGVTVVDID GDGSFLMNIQ ELALIRIENL PVKVMVLNNQ 540
HLGMVVQLED RFYKANRAHT YLGNPECESE IYPDFVTIAK GFNIPAVRVT KKSEVRAAIK 600
KMLETPGPYL LDIIVPHQEH VLPMIPSGGA FKDMILDGDG RTVY 644
//
ID DI500016 STANDARD; PRT; 17 AA.
XX
AC DI500016;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/116: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/116.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/116 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..17
XX
SQ SEQUENCE 17 AA; 2D19050E CRC32;
AISETGMHIY YADSVKG 17
//
ID DI500017 STANDARD; PRT; 3 AA.
XX
AC DI500017;
XX
DT 30-APR-2009
XX
DE KR 1020047013597-A/13: Conjugates of Therapeutic or Cytotoxic
DE Agents and Biologically Active Peptides.
XX
KW KR 1020047013597-A/13.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Fuselier,J.A. and Coy,D.H.;
RT "Conjugates of Therapeutic or Cytotoxic Agents and Biologically
RT Active Peptides";
RL Patent: KR 1020047013597-A/13 31-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..3
XX
SQ SEQUENCE 3 AA; 1F400F7 CRC32;
XKS 3
//
ID DI500018 STANDARD; PRT; 131 AA.
XX
AC DI500018;
XX
DT 30-APR-2009
XX
DE KR 1020030021065-A/6: Agent for inhibiting angiogenesis, containing
DE peptides which comprise YH motif as effective component.
XX
KW KR 1020030021065-A/6.
XX
OS Homo sapiens (human)
OC Homo sapiens
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC Catarrhini; Hominidae; Homo.
XX
RN []
RP [-]
RA Kim,I. and Nam,J.;
RT "Agent for inhibiting angiogenesis, containing peptides which
RT comprise YH motif as effective component";
RL Patent: KR 1020030021065-A/6 03-APR-2003.
XX
FH Key Location/Qualifiers
FT source 1..131
XX
SQ SEQUENCE 131 AA; A372711 CRC32;
MGTVMDVLKG DNRFSMLVAA IQSAGLTETL NREGVYTVFA PTNEAFRALP PRERSRLLGD 60
AKELANILKY HIGDEILVSG GIGALVRLKS LQGDKLEVSL KNNVVSVNKE PVAEPDIMAT 120
NGVVHVITNV L 131
//
ID DI500019 STANDARD; PRT; 124 AA.
XX
AC DI500019;
XX
DT 21-FEB-2008
XX
DE KR 1020047013038-A/39: Anti A-beta antibodies and their use.
XX
KW KR 1020047013038-A/39.
XX
OS synthetic construct
OC synthetic construct
OC other sequences; artificial sequences.
XX
RN []
RP [-]
RA Bardroff,M., Bohrmann,B., Brockhaus,M., Huber,W., Kretzschmar,T.,
RA Loehning,C., Roetscher,H., Nordstedt,C. and Rothe,C.;
RT "Anti A-beta antibodies and their use";
RL Patent: KR 1020047013038-A/39 20-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..124
XX
SQ SEQUENCE 124 AA; 1C4E2598 CRC32;
QLVESGGGLV QPGGSLRLSC AASGFTFSSY AMSWVRQAPG KGLEWVSAIN ADGNRKYYAD 60
SVKGRFTISR DNSKNTLYLQ MNSLRAEDTA VYYCARGKGN THKPYGYVRY FDVWGQGTLV 120
TVSS 124
//
ID DI500020 STANDARD; PRT; 754 AA.
XX
AC DI500020;
XX
DT 21-FEB-2008
XX
DE KR 1020047013224-A/164: METHOD FOR THE RECOMBINATION OF GENETIC
DE ELEMENTS.
XX
KW KR 1020047013224-A/164.
XX
OS Klebsiella pneumoniae
OC Klebsiella pneumoniae
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC Enterobacteriaceae; Klebsiella.
XX
RN []
RP [-]
RA Milano,J. and Tang,X.;
RT "METHOD FOR THE RECOMBINATION OF GENETIC ELEMENTS";
RL Patent: KR 1020047013224-A/164 25-AUG-2004.
XX
FH Key Location/Qualifiers
FT source 1..754
XX
SQ SEQUENCE 754 AA; 5633DF80 CRC32;
MKRSKRFAVL AQRPVNQDGL IGEWPEEGLI AMDSPFDPVS SVKVDNGLIV ELDGKRRDQF 60
DMIDRFIADY AINVERTEQA MRLEAVEIAR MLVDIHVSRE EIIAITTAIT PAKAVEVMAQ 120
MNVVEMMMAL QKMRARRTPS NQCHVTNLKD NPVQIAADAA EAGIRGFSEQ ETTVGIARYA 180
PFNALALLVG SQCGRPGVLT QCSVEEATEL ELGMRGLTSY AETVSVYGTE AVFTDGDDTP 240
WSKAFLASAY ASRGLKMRYT SGTGSEALMG YSESKSMLYL ESRCIFITKG AGVQGLQNGA 300
VSCIGMTGAV PSGIRAVLAE NLIASMLDLE VASANDQTFS HSDIRRTART LMQMLPGTDF 360
IFSGYSAVPN YDNMFAGSNF DAEDFDDYNI LQRDLMVDGG LRPVTEAETI AIRQKAARAI 420
QAVFRELGLP PIADEEVEAA TYAHGSNEMP PRNVVEDLSA VEEMMKRNIT GLDIVGALSR 480
SGFEDIASNI LNMLRQRVTG DYLQTSAIFD RQFEVVSAVN DINDYQGPGT GYRISAERWA 540
EIKNIPGVVQ PDTIEQGGIP VQQTTQIQPS FTLKTREGGV ASADERADEV VIGVGPAFDK 600
HQHHTLIDMP HGAILKELIA GVEEEGLHAR VVRILRTSDV SFMAWDAANL SGSGIGIGIQ 660
SKGTTVIHQR DLLPLSNLEL FSQAPLLTLE TYRQIGKNAA RYARKESPSP VPVVNDQMVR 720
PKFMAKAALF HIKETKHVVQ DAEPVTLHID LVRE 754
//
|
